Leitch, Ian M. http://orcid.org/0000-0002-2465-3036
Gerometta, Michael
Eichenbaum, David
Finger, Robert P.
Steinle, Nathan C.
Baldwin, Megan E.
Article History
Received: 4 March 2024
Accepted: 16 May 2024
First Online: 1 June 2024
Declarations
:
: Ian M. Leitch, Michael Gerometta, and Megan E. Baldwin are employees of Opthea Limited. David Eichenbaum is an investigator and consultant for Bayer, Eyepoint, Genentech, Ocular Therapeutix, Opthea, and Regeneron; is an investigator for AsclepiX and 4D Molecular Therapeutics; and is a speaker for Genentech. Robert P. Finger received consulting fees from Bayer, Novartis, Novelion, Opthea, Retina Implant, and Santen. Nathan C. Steinle received consulting fees from Alimera Sciences, Apellis Pharmaceuticals, Genentech, Novartis, Opthea, Regeneron, Regenxbio, Zeiss, and Vortex Surgical.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.